Dublin, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/wlm2kp/global)
has announced the addition of the "Global
Biosimilars Market - Products, Applications and Regulations"
report to their offering.
Off-Patent Biologics to Boost the Growth of Biosimilars Global
Market to Reach US$19.4bn by 2018
Several of the leading 25 manufacturers of biosimilars have been
entrenched in the market, and have the experience of marketing
products for the last 5-10 years. On the other hand, several
companies' position is expected to be challenged over the next ten
years, since the rapid growth forecast for the biosimilars market
has attracted several new companies to enter this lucrative arena.
Current leaders, in order to maintain market share, need to
introduce new biosimilars over the next few years with a specific
focus on the products in demand. Licensing deals are expected to
expand the pipelines of established players, as well as new market
entrants.
The global biosimilar market, estimated at US$2 billion in 2012 and
expected to touch US$2.7 billion in 2013, is further projected to
reach US$19.4 billion by 2018, exhibiting a CAGR of 36.6% over
2009-2018. This growth can be attributed to some of the top-selling
biologics coming off-patent over the coming few years and
biosimilar manufacturers are bound to make a beeline towards this
lucrative opportunity.
Publication Overview
This report reviews, analyzes and projects the biosimilars
market for global and regional markets including the United States,
Europe, Asia-Pacific and Rest of World. The market numbers
illustrated in this report only represent the market exclusively
for the product segments and application areas enunciated above.
The regional markets further analyzed for 8 more independent
countries across Europe - France, Germany, Italy, Spain, the United
Kingdom and Rest of Europe; Asia-Pacific - China, India, South
Korea and Rest of Asia-Pacific.
The market for application areas of biosimilars analyzed in this
study includes Blood Disorders, Chronic Diseases, Growth Hormone
Deficiency, Oncology and Others. The report also encompasses the
market analysis for product segments - Monoclonal Antibodies,
Erythropoietin, Human Growth Hormone, Insulin, G-CSF, Interferons
and Others.
This 354 page global market report includes 149 charts (includes a
data table and graphical representation for each chart), supported
with meaningful and easy to understand graphical presentation, of
the market. The statistical tables represent the data for the
global market by geographic region, application area and product
segment.The report covers the brief business profiles of 43 key
global players and 54 major players across the United States - 13;
Europe - 18; Asia-Pacific - 19 and Rest of World - 4. The report
also provides the listing of the companies engaged in research and
development, manufacturing, processing, supplies and distribution
of biosimilars. Also enlisting the academic institutions and
industry associations engaged in biosimilars, the global list
covers the addresses, contact numbers and the website addresses of
168 companies.
Key Topics Covered:
Part A: Global Market Perspective
1. Introduction
2. Biosimilar Applications - A Snapshot
3. Regulatory Landscape
4. Key Market Trends
5. Key Global Players
6. Key Business Trends
7. Global Market Overview
Part B: Regional Market Perspective
Regional Market Overview
1. The United States
2. Europe
3. Asia-Pacific
4. Rest Of World
Part C: Guide To The Industry
1. North America
2. Europe
3. Asia-Pacific
4. Rest Of World
Part D: Annexure
1. Research Methodology
2. The Questionnaire
3. Feedback
Charts & Graphs
Companies Mentioned
- 3SBio
- Amgen
- Astrazeneca
- Baxter International
- Biocon
- Biogen IDEC
- Bioton
- Cadila Healthcare
- Celltrion
- Daiichi Sankyo Company
- DSM Biologics
- GE Healthcare
- Glaxosmithkline
- iBio
- Merck
- Mitsubishi Tanabe Pharma Corporation
- Mylan
- Novartis
- Perkinelmer
- Pfizer Inc
- Roche Holding
- Samsung Biologics
- Sandoz International
- Sanofi
- Shantha Biotechnics
- Watson Pharmaceuticals
- Wockhardt Limited
For more information visit http://www.researchandmarkets.com/research/wlm2kp/global
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Pharmaceuticals